Therapy in Type 2 Diabetes: Insulin Glargine vs. NPH Insulin Both in Combination with Glimepiride
Tóm tắt
Từ khóa
Tài liệu tham khảo
1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6
1999, A desktop guide to type 2 diabetes mellitus. European Diabetes Policy Group 1999, Diabet Med, 16, 716
2004, Standards of medical care in diabetes, Diabetes Care, 27, S15
1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401
1998, Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8
2000, Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, N Engl J Med, 342, 381, 10.1056/NEJM200002103420603
Lawson, 1999, Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis, Diabetes Care, 22, B35
Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405
Wright, 2002, Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK. Prospective Diabetes Study (UKPDS 57), Diabetes Care, 25, 330, 10.2337/diacare.25.2.330
Riddle, 2003, Insulin Glargine 4002 Study Investigators. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients, Diabetes Care, 26, 3080, 10.2337/diacare.26.11.3080
Fritsche, 2003, Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial, Ann Intern Med, 138, 952, 10.7326/0003-4819-138-12-200306170-00006
McCrimmon, 1994, Hypoglycaemia, the most feared complication of insulin therapy, Diabet Metab, 20, 503
2001, Standards of medical care for patients with diabetes mellitus. American Diabetes Association Position Statement, Diabetes Care, 24, S33
Galloway, 1994, Improving insulin therapy: achievements and challenges, Horm Metab Res, 26, 591, 10.1055/s-2007-1001766
Lepore, 2000, Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro, Diabetes, 49, 2142, 10.2337/diabetes.49.12.2142
Yki-Järvinen, 2000, Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group, Diabetes Care, 23, 1130, 10.2337/diacare.23.8.1130
Heinemann, 2000, Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo, Diabetes Care, 23, 644, 10.2337/diacare.23.5.644
Yki-Järvinen, 2003, The relationship between HbA1c, fasting blood glucose (FBG) and hypoglycaemia using insulin glargine versus NPH insulin: a meta-regression analysis in Type 2 diabetes, Diabetes, 52, A149
Owens, 2000, Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites, Diabetes Care, 23, 813, 10.2337/diacare.23.6.813
Witthaus, 2001, Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes, Diabet Med, 18, 619, 10.1046/j.1464-5491.2001.00529.x
Home, 2005, A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes, Diabet Med